Regenxbio RGNX
NASDAQ RGNX
$7.45 -0.02 (-0.27%)
At close: Sep 29, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Notes Payables (2014)

Updated

Regenxbio (RGNX) recorded Notes Payables of $2.4 million in Q4 2014.

Analysis

Regenxbio (RGNX) Notes Payables (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Regenxbio 404.61 Mn -528.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 2.40 Mn
API Access

Regenxbio Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=RGNX&period=max&api_key=YOUR_API_KEY